Loretta Li

  • Source: Scopus
20032018

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

2010Internship, Boston Children's Hospital
2012Residency, Boston Children's Hospital
2015Fellowship, Boston Children's Hospital

Education/Academic qualification

MD, Harvard Medical School

… → 2009

Fingerprint

Dive into the research topics where Loretta Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
  • Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications

    Chiaretti, S., Messina, M., Grammatico, S., Piciocchi, A., Fedullo, A. L., Di Giacomo, F., Peragine, N., Gianfelici, V., Lauretti, A., Bareja, R., Martelli, M. P., Vignetti, M., Apicella, V., Vitale, A., Li, L. S., Salek, C., Elemento, O., Inghirami, G., Weinstock, D. M., Guarini, A. & 1 others, Foà, R., Jun 2018, In: British Journal of Haematology. 181, 5, p. 642-652 11 p.

    Research output: Contribution to journalArticlepeer-review

    15 Scopus citations
  • Erratum: The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice (Cancer Cell (2016) 29 (574–586))

    Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S. C., Plana, O., Montero, J., Stevenson, K. E., Rao, P., Vadhi, R., Andreeff, M., Armand, P., Ballen, K. K., Barzaghi-Rinaudo, P., Cahill, S. & 77 others, Clark, R. A., Cooke, V. G., Davids, M. S., DeAngelo, D. J., Dorfman, D. M., Eaton, H., Ebert, B. L., Etchin, J., Firestone, B., Fisher, D. C., Freedman, A. S., Galinsky, I. A., Gao, H., Garcia, J. S., Garnache-Ottou, F., Graubert, T. A., Gutierrez, A., Halilovic, E., Harris, M. H., Herbert, Z. T., Horwitz, S. M., Inghirami, G., Intlekofer, A. M., Ito, M., Izraeli, S., Jacobsen, E. D., Jacobson, C. A., Jeay, S., Jeremias, I., Kelliher, M. A., Koch, R., Konopleva, M., Kopp, N., Kornblau, S. M., Kung, A. L., Kupper, T. S., LeBoeuf, N. R., LaCasce, A. S., Lees, E., Li, L. S., Look, A. T., Murakami, M., Muschen, M., Neuberg, D., Ng, S. Y., Odejide, O. O., Orkin, S. H., Paquette, R. R., Place, A. E., Roderick, J. E., Ryan, J. A., Sallan, S. E., Shoji, B., Silverman, L. B., Soiffer, R. J., Steensma, D. P., Stegmaier, K., Stone, R. M., Tamburini, J., Thorner, A. R., van Hummelen, P., Wadleigh, M., Wiesmann, M., Weng, A. P., Wuerthner, J. U., Williams, D. A., Wollison, B. M., Lane, A. A., Letai, A., Bertagnolli, M. M., Ritz, J., Brown, M., Long, H., Aster, J. C., Shipp, M. A., Griffin, J. D. & Weinstock, D. M., Jul 11 2016, In: Cancer Cell. 30, 1, p. 183 1 p.

    Research output: Contribution to journalComment/debatepeer-review

    Open Access
    20 Scopus citations
  • The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S. C., Plana, O., Montero, J., Stevenson, K. E., Rao, P., Vadhi, R., Andreeff, M., Armand, P., Ballen, K. K., Barzaghi-Rinaudo, P., Cahill, S. & 77 others, Clark, R. A., Cooke, V. G., Davids, M. S., DeAngelo, D. J., Dorfman, D. M., Eaton, H., Ebert, B. L., Etchin, J., Firestone, B., Fisher, D. C., Freedman, A. S., Galinsky, I. A., Gao, H., Garcia, J. S., Garnache-Ottou, F., Graubert, T. A., Gutierrez, A., Halilovic, E., Harris, M. H., Herbert, Z. T., Horwitz, S. M., Inghirami, G., Intlekoffer, A. M., Ito, M., Izraeli, S., Jacobsen, E. D., Jacobson, C. A., Jeay, S., Jeremias, I., Kelliher, M. A., Koch, R., Konopleva, M., Kopp, N., Kornblau, S. M., Kung, A. L., Kupper, T. S., LaBoeuf, N., LaCasce, A. S., Lees, E., Li, L. S., Look, A. T., Murakami, M., Muschen, M., Neuberg, D., Ng, S. Y., Odejide, O. O., Orkin, S. H., Paquette, R. R., Place, A. E., Roderick, J. E., Ryan, J. A., Sallan, S. E., Shoji, B., Silverman, L. B., Soiffer, R. J., Steensma, D. P., Stegmaier, K., Stone, R. M., Tamburini, J., Thorner, A. R., van Hummelen, P., Wadleigh, M., Wiesmann, M., Weng, A. P., Wuerthner, J. U., Williams, D. A., Wollison, B. M., Lane, A. A., Letai, A., Bertagnolli, M. M., Ritz, J., Brown, M., Long, H., Aster, J. C., Shipp, M. A., Griffin, J. D. & Weinstock, D. M., Apr 11 2016, In: Cancer Cell. 29, 4, p. 574-586 13 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    111 Scopus citations
  • Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

    Wu, S. C., Li, L. S., Kopp, N., Montero, J., Chapuy, B., Yoda, A., Christie, A. L., Liu, H., Christodoulou, A., vanBodegom, D., vanderZwet, J., Layer, J. V., Tivey, T., Lane, A. A., Ryan, J. A., Ng, S. Y., DeAngelo, D. J., Stone, R. M., Steensma, D., Wadleigh, M. & 21 others, Harris, M., Mandon, E., Ebel, N., Andraos, R., Romanet, V., Dölemeyer, A., Sterker, D., Zender, M., Rodig, S. J., Murakami, M., Hofmann, F., Kuo, F., Eck, M. J., Silverman, L. B., Sallan, S. E., Letai, A., Baffert, F., Vangrevelinghe, E., Radimerski, T., Gaul, C. & Weinstock, D. M., Jul 13 2015, In: Cancer Cell. 28, 1, p. 29-41 13 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    56 Scopus citations
  • The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia

    Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., Tolliday, N., Inguilizian, H., Galinsky, I., Stone, R. M., DeAngelo, D. J., Roti, G., Aster, J. C., Hahn, W. C., Kung, A. L. & Stegmaier, K., Mar 1 2012, In: Journal of Clinical Investigation. 122, 3, p. 935-947 13 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    72 Scopus citations
If you made any changes in Pure these will be visible here soon.